Skip to content

Surgery for Traumatic Optic Neuropathy

Clinical Treatment of Traumatic Optic Neuropathy: Optic Nerve Decompression Randomized Controlled Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02711982
Enrollment
2
Registered
2016-03-17
Start date
2010-01-31
Completion date
2020-12-31
Last updated
2016-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Optic Neuropathy

Brief summary

The pathophysiology of Traumatic Optic Neuropathy (TON) include a primary and secondary mechanism of injury. At present, no studies validate a particular approach to the management of TON. There are three management lines for these patients that include 1)observation only;2)medical treatment with high or megadoses of methylprednisolone; and 3)surgical intervention. Studies have shown that forces applied to the frontal bone and malar eminences are transferred and concentrated in the area near the optic canal. The tight adherence of the optic nerve's dural sheath to the periosteum within the optic canal is also thought to contribute to this segment of the nerve being extremely susceptible to the deformative stresses of the skull bones. In this study, investigators aim to make a randomized controlled trial to certify the efficiency of optic nerve canal decompression for TON patients.

Detailed description

surgical intervention's efficiency and outcome for TON patients will be clearly present after this randomized controlled trial study.

Interventions

PROCEDUREOptic canal and optic nerve sheath decompression

within 5 days from trauma

DRUGmethylprednisolone

within 5 days from trauma

Sponsors

RenJi Hospital
CollaboratorOTHER
Shanghai Changzheng Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
10 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients with the history of Traumatic Brain Injury or Craniofacial Trauma * Optic nerve compression(intraneural edema, nerve sheath hematoma or canal fracture with impingement) * Amplitude and latency abnormal or Ratio of amplitude of abnormal to normal side.

Exclusion criteria

* Glasgow Coma Scale,Score\<8 * Patients with good Visual Acuity and Visual Evoked Potential amplitude ratio more than 50% * Other Contraindications for surgery

Design outcomes

Primary

MeasureTime frameDescription
Amplitude and Latency of Visual-Evoked Potentialfrom trauma day to 60 days after traumaName of Scale: Visual-Evoked Potential Physiological Parameter: Amplitude and Latency Questionnaire: Trauma day and 1 day, 2 days, 3 days, 7 days, 14 days, 30 days and 60 days after trauma. Two more test for the day before surgery(Medical) and the day after surgery(Medical). Measurement collection: Inpatient and outpatient

Secondary

MeasureTime frameDescription
Vision level of Visual Acuityfrom trauma day to 60 days after traumaName of Scale: Level Vision and Visual acuity chart from 0.1 to 1.5 Physiological Parameter: light perception, hand motion and Visual Acuity Chart from 0.1 to 1.5 Questionnaire: Trauma day and 1 day, 2 days, 3 days, 7 days, 14 days, 30 days and 60 days after trauma. Two more test for the day before surgery(Medical) and the day after surgery(Medical). Measurement collection: Inpatient and outpatient

Countries

China

Contacts

Primary ContactLijun Hou, MD,PhD
houlijunsmmu@163.com86 21 81885671
Backup ContactHai Jin, MD,PhD
kingsea300809@163.com86 21 81885688

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026